Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The influenza RNA polymerase complex (FluPol) is a heterotrimeric enzyme essential for influenza virus replication and transcription. It consists of three subunits, PB1, PB2, and PA, each contributing to its function. PB1 is the core transcriptase, PB2 binds to capped RNA primers, and PA possesses endonuclease activity for "cap-snatching." FluPol is a prime target for antiviral drugs due to its indispensable role in the viral life cycle.
Inhibition of viral RNA synthesis; disruption of cap-snatching; inhibition of polymerase activity
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Influenza RNA Polymerase Complex (FluPol).